Trigeminal neuralgia

Authors

  • Aldair Buckcanan Vargas UNIMED Health System – AirEvac International, Puntarenas, Costa Rica. Médico General.
  • Milena Mata Fuentes Hospital Clínica Bíblica, San José, Costa Rica. Médico General.
  • Karen Fonseca Artavia Globalmed, Heredia, Costa Rica. Médico General.

Keywords:

Pons Varolii; pain; fifth cranial nerve; compression, nerve root; microsurgery. Source: DeCS

Abstract

Trigeminal neuralgia is a disease whose prevalence is high and corresponds to a significant percentage of facial neuralgia; where the most affected people are over 50 years old. The clinical picture is usually of episodes of severe and recurring facial pain, unilateral; in the distribution of one or more divisions of the trigeminal nerve and this is not explained with another diagnosis. Diagnosis is based on the clinic and usually no sensory deficit is found, however, if present, neuroimaging should be done to rule out other causes. In the first instance is the pharmacological management. Carbamazepine has been established as effective, leading to pain relief within 24 hours. When pharmacological therapy fails, surgery is generally divided into two: techniques that destroy the sensitive portion of the nerve and microvascular decompression, which has the best results.

References

1- Zakrzewska JM, Akram H. Neurosurgical interventions for the treatment of classical trigeminal neuralgia. Cochrane Database of Systematic Reviews 2011, Issue 9. Art. No.: CD007312.

2- The International classification of headache disorders, 3rd edition. Cephalgia international headache society 2018: 18, 19, 20, 24 y 36.

3- Mittal B, Thomas D. Controlled thermocoagulation trigeminal neuralgia. J Neurol Neurosurg Psychiat 1986; 49: 932-936.

4- Katusic S, Williams DB, Beard CM, Bergstralh EJ, Kurland LT. Epidemiology and clinical features of idiopathic trigemi- nal neuralgia and glossopharyngeal neuralgia: similarities and differences, Rochester, Minnesota, 1945-1984. Neuroepi- demiology 1991;10:276-281.

5- Penman J. Trigeminal neuralgia. In: Vinken PJ, Bruyn GW,editors. Handbook of clinical neurology. Amsterdam: North Holland, 1968: 296-322.

6- Maxwell RE. Clinical diagnosis of trigeminal neuralgia and differential diagnosis of facial pain. In: Rovit RL. Murali R, Jannetta PJ. Editors. Trigeminal neuralgia. Baltimore; Williams & Wilkins, 1990: 53-57.

7- Rothman KJ, Monson RR. Epidemiology of trigeminal neuralgia. J Chron Dis 1973;26:2-12.

8- Beaver DL. Electron microscopy of the gasserian ganglion in trigeminal neuralgia. J Neurosurg 1963;20:138-150.

9- Buscaino GA. Fisiologia della nevralgia essenziale del trigemino. Acta Neurol 1980;35:137-144.

10- Afifi A, Bergman R. Functional neuroanatomy. New York: Lange Medical Books/McGraw-Hill; 2005.

11- Obermann M, Yoon M, Ese D, Maschke M, Kaube H, Diener H et al. Impaired trigeminal nociceptive processing in patients with trigeminal neuralgia. Neurology. 2007;69(9):835-841

12- Richard B. Tenser, MD. Trigeminal neuralgia mechanisms and treatment. Neurology 1998;51:17-19

13- Teruel A, Ram S, Kumar S, Hariri S, Clark G. Prevalence of hypertension in patients with trigeminal neuralgia. The Journal of Headache and Pain. 2009;10(3):199 .

14- Seth Love and Hugh B. Coakham. Trigeminal neuralgia Pathology and pathogenesis. Brain (2001), 124, 2348 y 2349.

15- Wiffen P, Derry S, Moore R, Kalso E. Carbamazepine for chronic neuropathic pain and fibromyalgia in adults. Cochrane Database of Systematic Reviews. 2014.

16- Gronseth G, Cruccu G, Alksne J, Argoff C, Brainin M, Burchiel K et al. Practice Parameter: The diagnostic evaluation and treatment of trigeminal neuralgia (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology and the European Federation of Neurological Societies. Neurology. 2008;71(15):1183-1190.

17- Zakrzewska J, Chaudhry Z, Nurmikko T, Patton D, Mullens L. Lamotrigine (Lamictal) in refractory trigeminal neuralgia: results from a double-blind placebo controlled crossover trial. Pain. 1997;73(2):223-230.

18- Reder A, Amason B. Trigeminal neuralgia in multiple sclerosis relieved by a prostaglandin E analogue. Neurology. 1995;45(6):1097-1100.

19- Zhang J, Yang M, Zhou M, He L, Chen N, Zakrzewska JM. Non-antiepileptic drugs for trigeminal neuralgia. Cochrane Database of Systematic Reviews 2013, Issue 12. Art. No.: CD004029. DOI: 10.1002/14651858.CD004029.pub4

20- Bennetto, L, Patel, N. and Fuller, G. (2007). Trigeminal neuralgia and its management. BMJ, 334(7586), pp.201-205.

21- Lopez B, Hamlyn P, Zakrzewska J. Systematic Review of Ablative Neurosurgical Techniques for the Treatment of Trigeminal Neuralgia. Neurosurgery. 2004;54(4):973-983.

22- Jannetta P. Microsurgical Management of Trigeminal Neuralgia. Archives of Neurology. 1985;42(8):800-800.

23- Nurmikko T, Eldridge P. Trigeminal neuralgia—pathophysiology, diagnosis and current treatment. British Journal of Anaesthesia. 2001;87(1):117-132.

24- Helis C, McTyre E, Munley M, Bourland J, Lucas J, Cramer C et al. Gamma Knife Radiosurgery for Multiple Sclerosis-Associated Trigeminal Neuralgia. Neurosurgery. 2019.

25- Tenser R. Trigeminal neuralgia: Mechanisms of treatment. Neurology. 1998;51(1):17-19.

26- Cucchiara B. Affected Side and Risk of Pain Recurrence After Surgery for Trigeminal Neuralgia. Archives of Neurology. 2003;60(8):1169. Disponible: https://www.ncbi.nlm.nih.gov/pubmed/12925379

27- Holste K, Chan A, Rolston J, Englot D. Pain Outcomes Following Microvascular Decompression for Drug-Resistant Trigeminal Neuralgia: A Systematic Review and Meta-Analysis. Neurosurgery. 2019.

Published

2020-11-17

Most read articles by the same author(s)